Table 3 Helicobacter (H) species in patients with benign biliary tract diseases
From: Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract
Reference | Country | Biological specimen | Method | Organism | H -positive/ total cases |
---|---|---|---|---|---|
PCR | Â | Â | Primer | Â | Â |
Italy | Bile | CagA (final product 298 bp) | CagA-positive H | 1/30 | |
Chile | Bile, tissue biopsies | 16S (C97–98 or C97–05) | H genus | 22/46 | |
 |  |  | Sequencing | H bilis a | 7/8 |
 |  |  | Sequencing | H pullorum | 1/8 |
Argentina | Bile | Not specified (final product 296 bp) | H genus | 2/26 | |
Germany | Bile | 16S (various species specific) | H genus | 0/73 | |
Korea | Bile, tissue biopsies | UreA (final product 258 bp) | H genus | 5/53 | |
 |  |  | 26kDa | H genus | 4/53 |
 |  | Stone | UreA or 26kDa | H genus | 7/53 |
 |  |  | UreA or 26kDa | H genus | 0/7 |
Japan | Bile, tissue biopsies | 16S (C97–98) | H genus | 2/53 | |
 |  |  | UreA (final product 258 bp) | UreA-positive H | 1/53 |
Mexico | Tissue biopsies | 16S (C97–98) | H genus | 1/95 | |
Serbia | Bile | UreA (final product 258 bp) | H genus | 35/65 | |
Sweden | Stone | 16S (species specific) | H pylori | 11/20 | |
Netherlands | Bile | 16S (various specific primers) | H pylori | 1/21 | |
New Zealand | Tissue biopsies | 16S (C97–98) | H genus | 46/85 | |
 |  |  | 26kDa | H genus | 31/46 |
 |  |  | 16S (species specific) | H pylori | 22/25 |
 |  |  | 16S (C62-C12) | H bilis | 0/85 |
Brazil | Bile, tissue biopsies | 16S (C97–98) | H genus | 18/46 | |
 |  |  | Sequencing | H pylori | 18/18 |
Iran | Stone | 16S (species specific) | H pylori | 6/33 | |
 |  | Bile | 16S (species specific) | H pylori | 4/33 |
Turkey | Stone | 16S (final product 349 bp) | H genus | 7/77 | |
Ukraine | Tissue biopsies | 16S (C97–98) | H genus | 16/22 | |
Italy | Bile, tissue biopsies | 16S (C95–98) | H genus | 17/33 | |
India | Bile | 16S | H genus | 29/30 | |
 |  |  | 16S (species specific) | H pylori | 10/29 |
 |  |  | UreA (final product 411 bp) | UreA-positive H | 10/29 |
 |  |  | CagA | CagA-positive H | 9/29 |
China | Tissue biopsies | UreA (final product 411 bp) | UreA-positive H | 15/81 | |
 |  |  | UreB (final product 132 bp) | UreB-positive H | 18/81 |
 |  |  | UreA or UreB | Ure-positive H | 22/81 |
India | Stone | 16S (species specific) | H pylori | 8/11 | |
Histology | Â | Â | Stain, antibodies, etc. | Â | Â |
UK | Tissue biopsies | Histopathology, H&E (PAS), Warthin-Starry | H pylori | 0/16b | |
Chile | Tissue biopsies | Histopathology, Warthin-Starry | H genus | 2/18 | |
Mexico | Tissue biopsies | Histopathology, H&E, Giemsa | H genus | 0/95 | |
 |  |  | Immuno-histopathology, polyclonal anti H pylori | H pylori | 1/95 |
Turkey | Tissue biopsies | Histopathology, H&E, gram, Warthin-Starry | H genus | 18/77 | |
Ukraine | Tissue biopsies | Immuno-histopathology, anti-CagA, anti-VacA, anti-H pylori | H pylori | 13/16c | |
China | Tissue biopsies | Histopathology, Warthin-Starry | H genus | 71/524 | |
 |  |  | Immuno-histopathology, polyclonal anti-H pylori | H pylori | 37/71d |
India | Tissue biopsies | Histopathology, H&E (PAS), Loeffler, Warthin Starry | H genus | 50/111b | |
 |  |  | Immuno-histopathology, polyclonal anti-H pylori | H pylori | 50/111b |
Culture | Â | Â | Conditions | Â | Â |
Chile | Bile, tissue biopsies | Frozen specimens, microaerophilic conditions | H genus | 0/46 | |
Japan | Bile | Frozen specimens, microaerophilic conditions | H genus | 0/39 | |
Brazil | Bile, tissue biopsies | Frozen specimens, microaerophilic conditions | H genus | 0/46 | |
Turkey | Tissue biopsies | Fresh specimens, microaerophilic conditions | Oxydase- and ure-positive H genus | 6/77 |